Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
October 21, 2022 at 11:00 AM EDT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|